This study aimed to investigate whether p16 exacerbates the severity of obesity‐related renal dysfunction and to elucidate the protective mechanisms by which p16 gene deletion influences renal cell senescence and kidney injury. The gene discussed is CDKN2A; the disease is obesity due to melanocortin 4 receptor deficiency.